Cellcyte Genetics Stock Current Valuation
Valuation analysis of Cellcyte Genetics helps investors to measure Cellcyte Genetics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Cellcyte Genetics OTC Stock Current Valuation Analysis
Cellcyte Genetics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Cellcyte Genetics Current Valuation | 545.78 K |
Most of Cellcyte Genetics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellcyte Genetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Cellcyte Genetics has a Current Valuation of 545.78 K. This is 100.0% lower than that of the Healthcare sector and 99.99% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Cellcyte Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellcyte Genetics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cellcyte Genetics could also be used in its relative valuation, which is a method of valuing Cellcyte Genetics by comparing valuation metrics of similar companies.Cellcyte Genetics is currently under evaluation in current valuation category among related companies.
Cellcyte Fundamentals
| Return On Equity | -22.9 | |||
| Return On Asset | -415.29 | |||
| Current Valuation | 545.78 K | |||
| Shares Outstanding | 82.33 M | |||
| Price To Earning | (0.90) X | |||
| EBITDA | (75.44 K) | |||
| Net Income | (141.63 K) | |||
| Total Debt | 537.55 K | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (49.67 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | 9.22 | |||
| Market Capitalization | 8.23 K | |||
| Total Asset | 2 K | |||
| Retained Earnings | (12.78 M) | |||
| Working Capital | (378 K) | |||
| Current Asset | 2 K | |||
| Current Liabilities | 380 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cellcyte Genetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cellcyte Genetics' short interest history, or implied volatility extrapolated from Cellcyte Genetics options trading.
Pair Trading with Cellcyte Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cellcyte Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellcyte Genetics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Marriott International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Marriott International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Marriott International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Marriott International to buy it.
The correlation of Marriott International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Marriott International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Marriott International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Marriott International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Cellcyte OTC Stock
If you are still planning to invest in Cellcyte Genetics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellcyte Genetics' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |